Three-Statement Breakdown
LITTLE CHANGED
Revenue was little changed at $29.9B year over year, and carried a 11.8% net margin.
REVENUE
-1.2%
29,940
GROSS PROFIT
—
—
NET INCOME
-68.3%
3,526
EPS (DILUTED)
-66.8%
$0.99
| Income statement | 24-09 | 24-12 | 25-03 | 25-06 | 25-09 | 25-12 | 26-03 | QoQ | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32,070 | 31,915 | 29,887 | 30,313 | 31,198 | 32,309 | 31,457 | 29,940 | -4.8% | -1.2% | |
| Operating income | 5,859 | 4,993 | 5,658 | 5,992 | 5,534 | 3,488 | 4,135 | 5,160 | +24.8% | -13.9% | |
| Interest expense | (1,037) | (1,069) | (1,050) | (1,105) | (1,128) | (1,126) | (1,094) | (1,052) | -3.8% | -4.8% | |
| Income tax | (1,243) | -1,111 | (1,196) | (3,603) | (1,218) | (89) | (706) | (1,194) | +69.1% | -66.9% | |
| Net income | 3,629 | 4,777 | 3,375 | 11,123 | 3,332 | 2,168 | 2,174 | 3,526 | +62.2% | -68.3% | |
| EPS (diluted) |
NOT DISCLOSED
10-Q
|
$0.94 | — | $0.89 | $2.98 | $0.90 | — | $0.60 | $0.99 | +65.0% | -66.8% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-23 ↗